Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | NOS2 | P35228 | 2/20 | 0.38 |
| ▸ | NOS3 | P29474 | 1/20 | 0.38 |
| ▸ | NOS1 | P29475 | 1/20 | 0.38 |
| ▸ | MBTD1 | Q05BQ5 | 1/20 | 0.36 |
| ▸ | L3MBTL3 | Q96JM7 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | BLM | P54132 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19853436 | 1.00 | L3MBTL1 (0.39) | L3MBTL1NOS2NOS3NOS1MBTD1 | |
| SCHEMBL215049 | 1.00 | L3MBTL1 (0.39) | L3MBTL1NOS2NOS3NOS1MBTD1 | |
| SCHEMBL27420810 | 1.00 | L3MBTL1 (0.39) | L3MBTL1NOS2NOS3NOS1MBTD1 | |
| SCHEMBL16563030 | 1.00 | L3MBTL1 (0.39) | L3MBTL1NOS2NOS3NOS1MBTD1 | |
| SCHEMBL9595528 | 1.00 | L3MBTL1 (0.39) | L3MBTL1NOS2NOS3NOS1MBTD1 | |
| SCHEMBL19211543 | 1.00 | L3MBTL1 (0.39) | L3MBTL1NOS2NOS3NOS1MBTD1 | |
| SCHEMBL12926132 | 1.00 | L3MBTL1 (0.39) | L3MBTL1NOS2NOS3NOS1MBTD1 | |
| SCHEMBL16763803 | 1.00 | L3MBTL1 (0.39) | L3MBTL1NOS2NOS3NOS1MBTD1 | |
| SCHEMBL474365 | 0.93 | — | — | |
| SCHEMBL27420798 | 0.93 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 125 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4427835-A1 | CARBON CAPTURE SOLVENTS AND METHODS FOR USING SUCH SOLVENTS | Carbon Clean Solutions Limited (GB) | 2024-09-11 | — | — | EP | claimed |
| EP-3660069-B1 | FAST CURING EPOXY SYSTEMS | EVONIK OPERATIONS GMBH (DE) | 2024-01-03 | — | — | EP | claimed |
| CN-117143010-A | Bipyridine diamine ligand and preparation method thereof | 山东农业大学 | 2023-12-01 | — | — | CN | claimed |
| EP-3569630-B1 | FAST CURING EPOXY SYSTEMS | EVONIK OPERATIONS GMBH (DE) | 2022-08-03 | — | — | EP | claimed |
| EP-3569629-B1 | FAST CURING EPOXY SYSTEMS | EVONIK OPERATIONS GMBH (DE) | 2022-07-06 | — | — | EP | claimed |
| EP-2968231-B1 | ANTIMICROBIAL POLYAMIDE COMPOSITIONS AND MASTITIS TREATMENT | BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC (US) | 2020-07-01 | — | — | EP | claimed |
| US-20200172723-A1 | FAST-CURING EPOXY SYSTEMS | EVONIK OPERATIONS GMBH (DE) | 2020-06-04 | — | — | US | claimed |
| EP-3660069-A1 | FAST CURING EPOXY SYSTEMS | Evonik Operations GmbH (DE) | 2020-06-03 | — | — | EP | claimed |
| US-20190352452-A1 | FAST-CURING EPOXY SYSTEMS | EVONIK DEGUSSA GMBH (DE) | 2019-11-21 | — | — | US | claimed |
| US-20190352449-A1 | FAST-CURING EPOXY SYSTEMS | EVONIK DEGUSSA GMBH (DE) | 2019-11-21 | — | — | US | claimed |
| EP-3569630-A1 | FAST CURING EPOXY SYSTEMS | Evonik Degussa GmbH (DE) | 2019-11-20 | — | — | EP | claimed |
| EP-3569629-A1 | FAST CURING EPOXY SYSTEMS | Evonik Degussa GmbH (DE) | 2019-11-20 | — | — | EP | claimed |
| EP-2968231-A1 | ANTIMICROBIAL POLYAMIDE COMPOSITIONS AND MASTITIS TREATMENT | Merial, Inc. (US) | 2016-01-20 | — | — | EP | claimed |
| WO-2014150451-A1 | ANTIMICROBIAL POLYAMIDE COMPOSITIONS AND MASTITIS TREATMENT | MERIAL LIMITED (US) | 2014-09-25 | — | — | WO | claimed |
| US-20140271526-A1 | ANTIMICROBIAL POLYAMIDE COMPOSITIONS AND MASTITIS TREATMENT | MERIAL LIMITED (US) | 2014-09-18 | — | — | US | claimed |
| CN-100531863-C | Polyamine/alkali salt blends for carbon dioxide removal from gas streams | UNIV TEXAS (US) | 2009-08-26 | — | — | CN | claimed |
| US-20070044658-A1 | Polyamine/alkali salt blends for carbon dioxide removal from gas streams | THE UNIVERSITY OF TEXAS SYSTEM (US) | 2007-03-01 | — | — | US | claimed |
| CN-1780677-A | Polyamine/alkali salt blends for carbon dioxide removal from gas streams | UNIV TEXAS (US) | 2006-05-31 | — | — | CN | claimed |
| EP-1615712-A1 | POLYAMINE/ALKALI SALT BLENDS FOR CARBON DIOXIDE REMOVAL FROM GAS STREAMS | BOARD OF REGENTS THE UNIVERSITY OF TEXAS SYSTEM (US) | 2006-01-18 | — | — | EP | claimed |
| WO-2004089512-A1 | POLYAMINE/ALKALI SALT BLENDS FOR CARBON DIOXIDE REMOVAL FROM GAS STREAMS | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2004-10-21 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140271526-A1 | ANTIMICROBIAL POLYAMIDE COMPOSITIONS AND MASTITIS TREATMENT | PUF60, PARG, PAM | L3MBTL1 1377/4885NOS2 37/4885NOS3 48/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.